Stockholm-based life sciences VC investing in precision medicine and breakthrough therapeutics. Over €800M raised across nine funds with a proven IPO and trade sale track record.
Auto-extracted from press releases.
Activity Trend
Light dataLast 90d
1
Prior 90d
1
Year ago
0
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.